Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Mechanism of Cardiac Arrhythmias
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Jillian Hall1, Daniel Edmundowicz1, Edmond Cronin1
1Section of Cardiology, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.
弗莱卡尼德的毒性会导致先进的心房间隔膜阻塞,严重的心脏导电异常. 这一案例凸显了在弗莱卡尼尼德治疗期间监测心脏功能的必要性.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: